Simpson Healthcare Executives: Challenging Healthcare Stakeholders to Think Differently

The world of healthcare is constantly changing. It is turning towards more innovative and disruptive strategy. For the past 20 years, Simpson Healthcare Executives has had the opportunity to work with great healthcare clients who strive to manage and develop disruptive therapeutic options that are most impactful for patients. Its medical and strategy teams have effectively become the catalysts of healthcare innovation.

The scientific expertise and disruptive thinking methods and behaviors of Simpson Healthcare span across a broad array of many major therapeutic categories, including respiratory, oncology, cardiovascular, immunology, rare diseases, gastrointestinal, adult vaccines, and severe asthma, to name a few.

In tete-a-tete with the Founder and CEO Kelly Simpson-Angelini

Simpson Healthcare is disruptive and that makes it different. Tell us more about it.

We have long studied how disruptive innovation has changed industries across markets and we are hands-on in applying this novel new theory of disruption, to the healthcare field. We think differently about why scientific stories of therapies matter for patients, as we aim to ensure the delivery of precision medicine: the right patient receiving the right medicine at the right time. We drive forward new scientific innovations and therapies for our clients that will disruptively transform healthcare worldwide and lead the industry into the future. We are proud to stand united with our clients as we help them to improve the quality of life for patients who will benefit most from their therapies.

Simpson Healthcare has undergone a significant growth period with a rich heritage. On what grounds has the company expanded and what are the offerings over the years?

The Simpson Healthcare team listens and looks beyond next year and into the next decades to understand how the greater healthcare landscape works. We collaboratively develop new scientific communication methods and marketing platforms that best support our clients’ needs and position them to achieve the best possible outcomes for their therapeutic brands that are most impactful for patients. We have used our passion for healthcare and disruptive innovation to build and customize specialized service offerings that provide long-term value to our clients’ business and the healthcare field.  Our work here has been launched with our top clients, and many others, who are disruptively transforming healthcare in the industry.

To expand our service offerings for our clients, Simpson Healthcare recently launched a new line of ‘Futuring’ work. During Futuring, we envision the potential best and worst futures without any reference to present day. Once the Futures have been imagined, the drivers to reach those futures are identified, which help to pinpoint opportunities to shape a “Desired Future,” or avoid impact from an “Undesirable Future.”

Simpson Healthcare is an award-winning agency that has undergone a period of consistent growth as an organization. What are the reasons behind it?

We believe our unique ability to be a disruptive and transformative catalyst of innovation within the ever-evolving healthcare industry has brought us here today. We have some of the brightest minds in science, business, and technology within our agency, and our highly collaborative internal team is central to the organization. Our senior leadership team excels in the management of people and ensures that we have the right people on every team to best support our healthcare clients and their goals; We ensure that our teams are well-balanced and well-equipped with all of the resources that we need to be successful, always looking and listening to collaboratively develop and implement new systems and processes that drive learnings, effectiveness, and efficiencies within the agency.

Tell us about your inspiration and factors that have contributed to your success.

Our internal teams are very passionate about what we do and how we contribute to the healthcare field, always keeping in mind the patient as the center of our focus. The real value of healthcare comes from our ability to grow our clients’ brands by delivering real value for patients. We bring the scientific strength of our agency forward and provide the disruptively innovative solutions that unlock our clients’ full potential to positively improve the quality of life for patients who could benefit most from their therapies. We embrace these core values at Simpson Healthcare: we maintain passion about making a difference; we keep it real by developing strong, authentic relationships; we look to the future by never losing sight of the larger context; know we are better together, and finally we bring our best selves to work every day.

Where do you see the company a couple of years from now?

The core stories of disease, diagnosis, and new therapies will continue to be new and abundant. We see huge opportunity to continue to build knowledge and skills in organizing and showcasing scientific content. We believe we will be supporting new types of products like gene therapies that are a simple once in a lifetime treatment.

The Pathfinder of Simpson Healthcare

Kelly Simpson-Angelini is the founder, CEO, and CSO of Simpson Healthcare Executives. She began her career as a Research Scientist at Pfizer in the 80s and soon developed a passion for science and penchant for scientific storytelling. It was soon after that she founded Simpson Healthcare Executives, an agency dedicated to supporting clients to share the scientific story of the diseases it touches and therapies they discover for all in need.  The Business Worldwide Magazine recognized and awarded Simpson-Angelini as 2017 Healthcare Industry CEO of the Year- USA and 2017 Most Innovative CEO of the Year-USA at the 2017 Business Worldwide CEO Awards. She takes an active role in mentoring and coaching women, internally and externally, and in 2016, she was named a Women of Innovation Honoree by the Connecticut Technology Council for her entrepreneurial vision and leadership. She currently serves as Chair of the Board of Directors at Can Do Multiple Sclerosis (MS), a non-profit organization that was founded by the Olympic skier, Jimmie Huega in 1984.

“Our purpose is to help our clients to share the scientific story of the diseases we touch and therapies discovered for all in need.”

We understand what it means to be human.